BNT162b2 vaccine effectiveness 92 percent for teens ages 12 to 17
(HealthDay)—For adolescents ages 12 to 17 years, the effectiveness of full vaccination with two doses of the Pfizer-BioNTech vaccine is 92 percent against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), according ...
Dec 31, 2021
0
4